Baker Bros. Capital (GP), LLC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Baker Bros. Capital (GP), LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Baker Bros. Capital (GP), LLC. Baker Bros. Capital (GP), LLC is a 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and a 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in INCYTE CORP ($INCY) and a Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and a 10% Owner in Diadexus, Inc. ($DDXS) and a 10% Owner in ADOLOR CORP ($ADLR) and a Director in Ardea Biosciences, Inc./DE ($IBPI) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX) and a 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).

Address: 667 MADISON AVENUE 21ST FLOOR NEW YORK US 10065 NY

Companies in which Baker Bros. Capital (GP), LLC is an Insider

ADOLOR CORP

Trading Symbol: ADLR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Jul 05 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Ardea Biosciences, Inc./DE

Trading Symbol: IBPI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: Director
Holdings: 126,709 shares
Latest Transaction: Jul 05 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

AUXILIUM PHARMACEUTICALS INC

Trading Symbol: AUXL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Jul 05 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

BIOCRYST PHARMACEUTICALS INC

Trading Symbol: BCRX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 62,407 shares
Current Value: $353,848
Latest Transaction: Jul 05 2011
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Diadexus, Inc.

Trading Symbol: DDXS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Jan 31 2012

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GENOMIC HEALTH INC

Trading Symbol: GHDX
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Baker Bros. Capital (GP), LLC: Director
Holdings: 187,135 shares
Current Value: $5,144,341
Latest Transaction: Jul 05 2011
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

HERON THERAPEUTICS, INC. /DE/

Trading Symbol: HRTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Jul 05 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

INCYTE CORP

Trading Symbol: INCY
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Baker Bros. Capital (GP), LLC: Director
Holdings: 227,594 shares
Current Value: $26,897,059
Latest Transaction: Jul 05 2011
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Seagen Inc.

Trading Symbol: SGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Bros. Capital (GP), LLC: Director
Holdings: 539,130 shares
Current Value: $32,773,713
Latest Transaction: Jan 04 2012
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

SYNAGEVA BIOPHARMA CORP

Trading Symbol: GEVA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Bros. Capital (GP), LLC: Director
Holdings: 220,692 shares
Latest Transaction: Nov 04 2011

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Baker Bros. Capital (GP), LLC

Sentiment: All, ADLR, IBPI, AUXL, BCRX, DDXS, GHDX, HRTX, INCY, SGEN, GEVA

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 31 2012	DDXS	Diadexus, Inc.	Baker Bros. Capital (GP), LLC	10% Owner	Sell	S	0.22	59,340	13,156	0	59.3 K to 0 (-100.00 %)
Jan 20 2012	DDXS	Diadexus, Inc.	Baker Bros. Capital (GP), LLC	10% Owner	Sell	S	0.20	20,000	4,000	59,340	79.3 K to 59.3 K (-25.21 %)
Jan 20 2012	DDXS	Diadexus, Inc.	Baker Bros. Capital (GP), LLC	10% Owner	Sell	S	0.21	118,800	25,233	79,340	198.1 K to 79.3 K (-59.96 %)
Jan 04 2012	SGEN	SEATTLE GENETICS I ...	Baker Bros. Capital (GP), LLC	Director	Option Exercise	X	6.25	68,006	425,038	0
Jan 04 2012	SGEN	SEATTLE GENETICS I ...	Baker Bros. Capital (GP), LLC	Director	Buy	X	6.25	68,006	425,038	539,130	471.1 K to 539.1 K (+14.43 %)
Nov 04 2011	GEVA	SYNAGEVA BIOPHARMA ...	Baker Bros. Capital (GP), LLC	Director	Grant	A	0.00	474	0	220,692	220.2 K to 220.7 K (+0.22 %)
Nov 04 2011	GEVA	SYNAGEVA BIOPHARMA ...	Baker Bros. Capital (GP), LLC	Director	Grant	A	0.00	76,484	0	220,218	143.7 K to 220.2 K (+53.21 %)

View all Baker Bros. Capital (GP), LLC insider transactions.